CREALITY 3D: Creality Shines at Formnext 2024, Unveils K2 Plus, New CoreXY Model, and Accessories
Creality made a strong impression at Formnext 2024, continuing its legacy as a leading innovator in 3D printing technology.
IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense Cryoablation
FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025 Conference call to be held today at 10:00 am Eastern Time CAESAREA ...
Highmark Health revenue grows 9% year over year to $22.1 billion; reports $529 million net income through third quarter of 2024
Insurance business units report positive operating performance while facing mounting industry-wide cost pressures Allegheny Health Network reports 9% total revenue ...
KeyBank Invests $300,000 in Indianapolis Urban League to Expand Entrepreneurship Center Program
NORTHAMPTON, MA / ACCESSWIRE / November 26, 2024 / KeyBankIUL plans to enhance the ECP by offering more comprehensive programming and services tailored to each entrepreneur's business stage at the tim ...
VinFast Reports Unaudited Third Quarter 2024 Financial Results
VinFast Auto Ltd. ("VinFast" or the "Company") (Nasdaq: VFS), a pure-play electric vehicle ("EV") manufacturer with the mission of making EVs accessible ...
Western Uranium & Vanadium Corp. Provides Company Updates
Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) ("Western" or the "Company") is providing the following updates: Geologist ...
Everest Group Names SS&C Blue Prism a Leader in Process Orchestration Products PEAK Matrix 2024
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced SS&C Blue Prism has been named a process orchestration Leader in the Everest Group ...
Manchester United PLC Reports First Quarter Fiscal 2025 Results
Manchester United (NYSE: MANU; the "Company" and the "Group") today announced financial results for the 2025 fiscal first quarter ended 30 September 2024. Management ...
Ensysce Biosciences Inc.: Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial
Landmark Overdose Protection Clinical Trial of PF614-MPAR ~~ Expects Early Interim Data in 1Q 2025 ~ SAN DIEGO, CA / ACCESSWIRE / November 26, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" ...
Racing Force S.p.A.: Racing Force gets certification in Bahrain as Authorized Economic Operator by the GCC
The recognition of the Gulf Cooperation Council will guarantee several commercial benefits and will improve the Group's operational efficiency Racing Force Group is proud to announce that its subsidia ...
Heliostar Metals Ltd.: Heliostar Announces First Results from 2024 Drilling Program at La Colorada Mine
HIGHLIGHTS:5.0m grading 18.0 g/t gold37.0m grading 1.24 g/t gold11.8m grading 1.71 g/t gold14.5m grading 1.69 g/t gold10.1m grading 0.85 g/t goldFive drill rigs operating at site completing a 12,500m ...
The J.M. Smucker Co. Announces Fiscal 2025 Second Quarter Results
The J.M. Smucker Co. (NYSE: SJM) today announced results for the second quarter ended October 31, 2024, of its 2025 ...